Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response

T细胞受体 免疫疗法 抗原 生物 癌症研究 链霉菌 免疫系统 T细胞 细胞毒性T细胞 CD8型 免疫学 体外 生物化学
作者
Jingjing He,Xinxin Xiong,Han Yang,Dandan Li,Xuefei Liu,Shuo Li,Shuangye Liao,Siyu Chen,Xizhi Wen,Kuai Yu,Lingyi Fu,Xingjun Dong,Kaiyu Zhu,Xiaojun Xia,Tiebang Kang,Chaochao Bian,Xiang Li,Haiping Liu,Peirong Ding,Xiaoshi Zhang
出处
期刊:Cell Research [Springer Nature]
卷期号:32 (6): 530-542 被引量:171
标识
DOI:10.1038/s41422-022-00627-9
摘要

Personalized immunotherapy targeting tumor-specific antigens (TSAs) could generate efficient and safe antitumor immune response without damaging normal tissues. Although neoantigen vaccines have shown therapeutic effect in clinic trials, precise prediction of neoantigens from tumor mutations is still challenging. The host antitumor immune response selects and activates T cells recognizing tumor antigens. Hence, T cells engineered with T-cell receptors (TCRs) from these naturally occurring tumor antigen-specific T (Tas) cells in a patient will target personal TSAs in his/her tumor. To establish such a personalized TCR-T cell therapy, we comprehensively characterized T cells in tumor and its adjacent tissues by single-cell mRNA sequencing (scRNA-seq), TCR sequencing (TCR-seq) and in vitro neoantigen stimulation. Compared to bystander T cells circulating among tissues, Tas cells were characterized by tumor enrichment, tumor-specific clonal expansion and neoantigen specificity. We found that CXCL13 is a unique marker for both CD4+ and CD8+ Tas cells. Importantly, TCR-T cells expressing TCRs from Tas cells showed significant therapeutic effects on autologous patient-derived xenograft (PDX) tumors. Intratumoral Tas cell levels measured by CXCL13 expression precisely predicted the response to immune checkpoint blockade, indicating a critical role of Tas cells in the antitumor immunity. We further identified CD200 and ENTPD1 as surface markers for CD4+ and CD8+ Tas cells respectively, which enabled the isolation of Tas cells from tumor by Fluorescence Activating Cell Sorter (FACS) sorting. Overall, our results suggest that TCR-T cells engineered with Tas TCRs are a promising agent for personalized immunotherapy, and intratumoral Tas cell levels determine the response to immunotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
搜集达人的应助被Kerizn采纳,获得10
刚刚
刚刚
SUN完成签到 ,获得积分10
刚刚
刚刚
英俊的铭的应助被STEAM采纳,获得10
1秒前
1秒前
材料牛马发布了新的文献求助10
1秒前
2秒前
lanlandetian发布了新的文献求助30
2秒前
SU完成签到,获得积分10
2秒前
MW完成签到,获得积分10
3秒前
呆萌的莲完成签到,获得积分10
3秒前
Bai_shao完成签到,获得积分10
4秒前
Bay发布了新的文献求助10
4秒前
沈英明完成签到,获得积分10
4秒前
Maverick发布了新的文献求助10
4秒前
顶顶小明完成签到,获得积分10
4秒前
fu发布了新的文献求助10
4秒前
脑洞疼的应助被lxn采纳,获得10
5秒前
吹走霉运发布了新的文献求助30
5秒前
大力的凡旋完成签到,获得积分10
5秒前
Liliz完成签到 ,获得积分10
5秒前
molihuakai的应助被踏实平萱采纳,获得10
6秒前
6秒前
6秒前
newwen完成签到,获得积分10
7秒前
cc发布了新的文献求助10
7秒前
Agoni完成签到,获得积分10
7秒前
Au完成签到 ,获得积分10
8秒前
乐乐的应助被材料牛马采纳,获得10
8秒前
LH完成签到,获得积分10
8秒前
合适的修洁完成签到,获得积分10
9秒前
yier发布了新的文献求助10
9秒前
Jasper的应助被QQ采纳,获得10
9秒前
window1000发布了新的文献求助10
10秒前
Abathur完成签到,获得积分10
10秒前
yang完成签到,获得积分10
10秒前
霍双帅发布了新的文献求助10
11秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570485
关于积分的说明 21812623
捐赠科研通 7776592
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557522
邀请新用户注册赠送积分活动 2479162